Related Experiment Video
Updated: May 30, 2026

Analysis of SCAP N-glycosylation and Trafficking in Human Cells
Published on: November 8, 2016
mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway
Timothy R Peterson1, Shomit S Sengupta, Thurl E Harris
1Whitehead Institute for Biomedical Research, Koch Center for Integrative Cancer Research at MIT, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
The nutrient kinase mTOR complex 1 (mTORC1) controls growth by regulating lipin 1 nuclear entry. This mechanism impacts SREBP activity, influencing gene transcription and metabolic disease resistance in mice.
Area of Science:
- Cellular Biology
- Metabolism
- Molecular Biology
Background:
- The mechanistic target of rapamycin complex 1 (mTORC1) is a key regulator of cellular growth and metabolism.
- Sterol regulatory element-binding proteins (SREBPs) are crucial transcription factors for lipid and cholesterol synthesis.
- The precise mechanisms by which mTORC1 influences SREBP activity remain incompletely understood.
Purpose of the Study:
- To elucidate the molecular mechanism linking mTORC1 signaling to SREBP function.
- To investigate the role of lipin 1 in mediating mTORC1-dependent regulation of lipogenesis and sterolgenesis.
- To determine the in vivo relevance of the mTORC1-lipin 1-SREBP pathway in diet-induced metabolic disorders.
Main Methods:
- Utilized biochemical assays to assess protein interactions and enzymatic activity.
- Employed cell-based assays to monitor SREBP target gene expression and promoter activity.
- Conducted in vivo studies using mouse models with liver-specific mTORC1 inhibition and high-fat/cholesterol diets.
Main Results:
- Demonstrated that mTORC1 controls the nuclear translocation of lipin 1, a phosphatidic acid phosphatase.
- Showed that dephosphorylated, nuclear lipin 1 is essential for mediating mTORC1's effects on SREBP activity and target gene expression.
- Found that inhibiting hepatic mTORC1 confers resistance to diet-induced hepatic steatosis and hypercholesterolemia, dependent on lipin 1.
Conclusions:
- Established lipin 1 as a critical mediator in the mTORC1-SREBP signaling axis.
- Identified the nuclear entry of lipin 1 as a key regulatory step controlled by mTORC1.
- Highlighted the therapeutic potential of targeting the mTORC1-lipin 1 pathway for metabolic diseases.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Nuclear Protein Sorting
Lipid Catabolism
The JAK-STAT Signaling Pathway
